Open AccessMoxinidine in the correction of metabolic disturbancis and endothelial dysfunction in patients with diabetes mellitus associated with arterial hypertension
Author(s) -
T. U. Demidova,
А.С. Аметов,
Л. В. Смагина
Publication year - 2004
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2004-10-2-104-109
Subject(s) - moxonidine , medicine , diabetes mellitus , blood pressure , imidazoline receptor , cardiology , type 2 diabetes mellitus , agonist , endothelial dysfunction , endocrinology , receptor
The paper presents the results of a follow-up and treatment of 30 patients with arterial hypertension (AH) accompanied by the persistent blood pressure elevation that requires continuous antihypertensive therapy and that is associated with type 2 diabetes mellitus. It shows the antihypersensive effect of the imidazoline-receptor agonist moxonidine and its positive action on metabolic parameters and a risk for cardiovascular events in this group of patients.